Commission Implementing Regulation (EU) 2023/1705 of 7 September 2023 concerning the authorisation of a preparation of riboflavin (vitamin B2) produced by Bacillus subtilis CGMCC 13326 as a feed additive for all animal species
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
Draft Joint Committee Decision (JCD) under consideration by the EU (EEAS) and the EFTA States (Iceland, Liechtenstein and Norway) Area (EEA Agreement)
I Veterinary and Phytosanitary Matters
I.II Feedingstuffs
Legal documents
Commission Implementing Regulation (EU) 2023/1705 of 7 September 2023 concerning the authorisation of a preparation of riboflavin (vitamin B2) produced by Bacillus subtilis CGMCC 13326 as a feed additive for all animal species
Durchführungsverordnung (EU) 2023/1705 der Kommission vom 7. September 2023 zur Zulassung einer Zubereitung aus Riboflavin (Vitamin B2), hergestellt aus Bacillus subtilis CGMCC 13326 als Zusatzstoff in Futtermitteln für alle Tierarten
History
08.11.2023
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
07.09.2023
Adoption date in the EU
28.09.2023
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.